We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid UTI Test System Combines an Immunoassay with a Smartphone Camera

By LabMedica International staff writers
Posted on 22 Jan 2020
Print article
Image: A smartphone camera is an important component of a new assay system for the detection of E. coli in urine samples (Photo courtesy of University of Bath)
Image: A smartphone camera is an important component of a new assay system for the detection of E. coli in urine samples (Photo courtesy of University of Bath)
A team of British bioengineers has combined a rapid microfluidic fluorescence sandwich immunoassay with a smartphone camera to form an assay system for the diagnosis of urinary tract infections (UTIs).

In its initial configuration, the assay is set to detect the bacterium Escherichia coli, which is found in about 80% of bacterial UTIs.

The test, as designed by investigators at the University of Bath (United Kingdom), is performed by passing a urine sample over a ridged plastic micro-capillary strip, to which are bound immobilized antibodies able to recognize E. coli bacteria. If E. coli are present in the sample, the antibodies will bind to them, preventing the bacteria from passing through that section of the plastic strip. An enzyme is added that causes a change in color that can be recorded by the smartphone camera. An application determines the concentration of E. coli in the sample by analyzing the image taken by the camera.

A prototype of the system operating with E. coli in synthetic urine was shown to be able to detect a minimal concentration of 240 CFU/mL (colony forming units per milliliter) of bacteria, compatible with cut-off levels for UTIs. The test took less than 25 minutes and did not require any sample preparation or concentration.

Senior author Dr. Nuno Reis, reader in the department of chemical engineering at the University of Bath, said, "The test is small and portable - so it has major potential for use in primary care settings and in developing countries. Currently, bacterial infections in UTIs are confirmed via microbiological testing of a urine sample. That is accurate, but time-consuming, taking several days. We hope that giving medical professionals the ability to quickly rule in or rule out certain conditions will allow them to treat patients more quickly and help them make better decisions about the prescription of antibiotics. The smartphone solves one of the biggest problems of the decentralizing of diagnostics because their capabilities are actually very sophisticated in certain conditions. They offer the same functionality as sophisticated scanners that have until now been available only in labs."

The rapid UTI test was described in the December 1, 2019, online edition of the journal Biosensors and Bioelectronics.

Related Links:
University of Bath

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultrasonic Cleaner
UC 300 Series
New
Calprotectin Assay
Fecal Calprotectin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.